Fig. 4From: Methylation of SERPINA1 gene promoter may predict chronic obstructive pulmonary disease in patients affected by acute coronary syndromeBoxplot graph resuming the lymphocyte count in acute coronary syndrome (ACS) patients with chronic obstructive pulmonary disease (COPD+) and without COPD (COPD−) during patient a admission and b discharge. Lymphocyte count in COPD+ and COPD− patients in c admission and d discharge according to SERPINA1 promoter hypermethylated (white) and hypomethylated (grey) statuses. All panels: the lower (Q1) and upper (Q3) quartile, represent observations outside the 5–95 percentile range. The graph also shows the median (continuous middle line) and the mean (dashed line) of lymphocytes (× 103 cell/µl) per study group. *p < 0.05Back to article page